BDBM505413 (S)-6-(((1-cyclopropyl-1H-1,2,3- triazol-4-yl)(1-oxoisoindolin- 4-yl)methyl)amino)-4- (neopentylamino)quinoline- 3,8-dicarbonitrile::BDBM505467::US11066414, Compound 76

SMILES CC(C)(C)CNc1c(cnc2c(cc(N[C@H](C3=CN(NN3)C3CC3)c3cccc4C(=O)NCc34)cc12)C#N)C#N

InChI Key InChIKey=PNQZRABOAVVILD-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 505413   

TargetEpidermal growth factor receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM505413(BDBM505467 | US11066414, Compound 76 | (S)-6-(((1-...)
Affinity DataIC50: 1nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
Go to US Patent

TargetEpidermal growth factor receptor(Human)
Gilead Sciences

US Patent
LigandPNGBDBM505413(BDBM505467 | US11066414, Compound 76 | (S)-6-(((1-...)
Affinity DataIC50: 3nMAssay Description:EGFR activity was measured using KinEASE (Cisbio), a time-resolved fluorescence resonance energy transfer (TR-FRET) immunoassay. In this assay, EGFR-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/23/2021
Entry Details
Go to US Patent